Harald H.
- Country
- Norway
- Department
- 2700:Kreftavdelingen
Research Overview
Data & Insights
Has run more than one trial at 0 of 18 partner sites.
Specializations
Hematologic Oncology
The investigator specializes in treating advanced forms of B-cell non-Hodgkin lymphoma, with particular focus on aggressive manifestations of this disease. Their expertise extends to managing cases that have proven resistant to conventional treatments.
- Aggressive lymphoma variants
- Relapsed/refractory disease management
- Advanced B-cell malignancies
Their work encompasses innovative therapeutic approaches for adult patients with challenging hematologic conditions.
Cellular Therapy
The investigator demonstrates expertise in tisagenlecleucel treatment, focusing on its application in adult patients with aggressive lymphomas. Their interest lies in developing treatment strategies that improve patient outcomes.
- CAR T-cell therapy
- Novel therapeutic approaches
- Treatment resistance strategies
Their work involves evaluating therapeutic responses and survival outcomes in advanced hematologic malignancies.
Disease Monitoring
The investigator focuses on disease progression assessment and treatment response evaluation in lymphoma patients. Their expertise includes monitoring therapeutic outcomes and survival metrics.
- Response assessment
- Disease stability monitoring
- Long-term outcome evaluation
Their approach incorporates comprehensive disease monitoring strategies for optimal patient care.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.